NCT05716516View on ClinicalTrials.gov

STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)

PHASE2RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 4, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2027

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Estradiol

Estradiol is a therapeutic option for the treatment of advanced ER+ breast cancer

Trial Locations (1)

03756

RECRUITING

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER